
Syed Taha Iqbal
Examiner (ID: 5838, Phone: (571)270-5857 , Office: P/1736 )
| Most Active Art Unit | 1736 |
| Art Unit(s) | 1793, 1736 |
| Total Applications | 941 |
| Issued Applications | 713 |
| Pending Applications | 67 |
| Abandoned Applications | 178 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 15264839
[patent_doc_number] => 20190381153
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-19
[patent_title] => BOTULINUM NEUROTOXINS WITH MODIFIED LIGHT CHAIN SPECIFITY AND METHODS FOR PRODUCING SAME
[patent_app_type] => utility
[patent_app_number] => 16/557450
[patent_app_country] => US
[patent_app_date] => 2019-08-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6614
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16557450
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/557450 | Botulinum neurotoxins with modified light chain specificity and methods for producing same | Aug 29, 2019 | Issued |
Array
(
[id] => 15290777
[patent_doc_number] => 20190388524
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-12-26
[patent_title] => TREATMENT AND DETECTION OF TRYPANOSOMES
[patent_app_type] => utility
[patent_app_number] => 16/503687
[patent_app_country] => US
[patent_app_date] => 2019-07-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11476
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -6
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16503687
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/503687 | TREATMENT AND DETECTION OF TRYPANOSOMES | Jul 4, 2019 | Abandoned |
Array
(
[id] => 17329275
[patent_doc_number] => 11219717
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-01-11
[patent_title] => Botulinum toxin prefilled plastic syringe
[patent_app_type] => utility
[patent_app_number] => 16/459382
[patent_app_country] => US
[patent_app_date] => 2019-07-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 11432
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 80
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16459382
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/459382 | Botulinum toxin prefilled plastic syringe | Jun 30, 2019 | Issued |
Array
(
[id] => 17236872
[patent_doc_number] => 11180744
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-11-23
[patent_title] => Acinetobacter lysins
[patent_app_type] => utility
[patent_app_number] => 16/454045
[patent_app_country] => US
[patent_app_date] => 2019-06-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 40
[patent_figures_cnt] => 37
[patent_no_of_words] => 12973
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 102
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16454045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/454045 | Acinetobacter lysins | Jun 25, 2019 | Issued |
Array
(
[id] => 15035585
[patent_doc_number] => 20190328797
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-31
[patent_title] => PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING METABOLIC DISEASES, COMPRISING BACTEROIDES ACIDIFACIENS AS ACTIVE INGREDIENT
[patent_app_type] => utility
[patent_app_number] => 16/443501
[patent_app_country] => US
[patent_app_date] => 2019-06-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -2
[patent_words_short_claim] => 25
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16443501
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/443501 | Pharmaceutical composition for preventing or treating metabolic diseases, comprising bacteroides acidifaciens as active ingredient | Jun 16, 2019 | Issued |
Array
(
[id] => 14990937
[patent_doc_number] => 20190314426
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => HUMAN-DERIVED BACTERIA THAT INDUCE PROLIFERATION OR ACCUMULATION OF REGULATORY T CELLS
[patent_app_type] => utility
[patent_app_number] => 16/427899
[patent_app_country] => US
[patent_app_date] => 2019-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33493
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 96
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16427899
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/427899 | Human-derived bacteria that induce proliferation or accumulation of regulatory T cells | May 30, 2019 | Issued |
Array
(
[id] => 14926351
[patent_doc_number] => 20190298813
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-03
[patent_title] => PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY
[patent_app_type] => utility
[patent_app_number] => 16/416758
[patent_app_country] => US
[patent_app_date] => 2019-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4745
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16416758
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/416758 | PHARMACEUTICAL LIQUID COMPOSITION OF BOTULINUM TOXIN WITH IMPROVED STABILITY | May 19, 2019 | Abandoned |
Array
(
[id] => 16414724
[patent_doc_number] => 10822601
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-11-03
[patent_title] => Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell
[patent_app_type] => utility
[patent_app_number] => 16/394951
[patent_app_country] => US
[patent_app_date] => 2019-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 53193
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 228
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16394951
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/394951 | Methods for producing multiple recombinant polypeptides in a filamentous fungal host cell | Apr 24, 2019 | Issued |
Array
(
[id] => 14994451
[patent_doc_number] => 20190316183
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-10-17
[patent_title] => FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE
[patent_app_type] => utility
[patent_app_number] => 16/390575
[patent_app_country] => US
[patent_app_date] => 2019-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37936
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16390575
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/390575 | FAST DIAGNOSIS AND PERSONALIZED TREATMENTS FOR ACNE | Apr 21, 2019 | Abandoned |
Array
(
[id] => 16650002
[patent_doc_number] => 10927165
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-02-23
[patent_title] => Antibodies that neutralize botulinum neurotoxins
[patent_app_type] => utility
[patent_app_number] => 16/389705
[patent_app_country] => US
[patent_app_date] => 2019-04-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 13
[patent_no_of_words] => 40139
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16389705
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/389705 | Antibodies that neutralize botulinum neurotoxins | Apr 18, 2019 | Issued |
Array
(
[id] => 15724323
[patent_doc_number] => 10610576
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-04-07
[patent_title] => Precision glycoconjugates as therapeutic tools
[patent_app_type] => utility
[patent_app_number] => 16/362363
[patent_app_country] => US
[patent_app_date] => 2019-03-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 51
[patent_figures_cnt] => 57
[patent_no_of_words] => 28703
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 138
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16362363
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/362363 | Precision glycoconjugates as therapeutic tools | Mar 21, 2019 | Issued |
Array
(
[id] => 14566919
[patent_doc_number] => 20190211066
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-11
[patent_title] => VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS
[patent_app_type] => utility
[patent_app_number] => 16/360085
[patent_app_country] => US
[patent_app_date] => 2019-03-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16360085
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/360085 | VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS | Mar 20, 2019 | Abandoned |
Array
(
[id] => 14808779
[patent_doc_number] => 20190270999
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-09-05
[patent_title] => METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT
[patent_app_type] => utility
[patent_app_number] => 16/298715
[patent_app_country] => US
[patent_app_date] => 2019-03-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16298715
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/298715 | METHOD FOR MODULATING GENE EXPRESSION BY MODIFYING THE CPG CONTENT | Mar 10, 2019 | Abandoned |
Array
(
[id] => 14682369
[patent_doc_number] => 20190240299
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-08-08
[patent_title] => Suture Line Administration Technique Using Botulinum Toxins
[patent_app_type] => utility
[patent_app_number] => 16/291383
[patent_app_country] => US
[patent_app_date] => 2019-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14673
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16291383
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/291383 | Suture line administration technique using botulinum toxins | Mar 3, 2019 | Issued |
Array
(
[id] => 17490630
[patent_doc_number] => 11279922
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-22
[patent_title] => Delivery of therapeutic agents by a collagen binding protein
[patent_app_type] => utility
[patent_app_number] => 16/283468
[patent_app_country] => US
[patent_app_date] => 2019-02-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 52
[patent_no_of_words] => 14262
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 159
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16283468
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/283468 | Delivery of therapeutic agents by a collagen binding protein | Feb 21, 2019 | Issued |
Array
(
[id] => 17307332
[patent_doc_number] => 11208424
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-12-28
[patent_title] => None
[patent_app_type] => utility
[patent_app_number] => 16/274822
[patent_app_country] => US
[patent_app_date] => 2019-02-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 19471
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 75
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16274822
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/274822 | None | Feb 12, 2019 | Issued |
Array
(
[id] => 15321163
[patent_doc_number] => 20200000911
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-01-02
[patent_title] => IMMUNOGENIC COMPOSITION
[patent_app_type] => utility
[patent_app_number] => 16/268287
[patent_app_country] => US
[patent_app_date] => 2019-02-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18276
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16268287
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/268287 | IMMUNOGENIC COMPOSITION | Feb 4, 2019 | Abandoned |
Array
(
[id] => 16695514
[patent_doc_number] => 10946083
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Anti-microbial immunomodulation
[patent_app_type] => utility
[patent_app_number] => 16/264040
[patent_app_country] => US
[patent_app_date] => 2019-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 17
[patent_figures_cnt] => 33
[patent_no_of_words] => 35747
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16264040
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/264040 | Anti-microbial immunomodulation | Jan 30, 2019 | Issued |
Array
(
[id] => 14621841
[patent_doc_number] => 20190224288
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-07-25
[patent_title] => THERAPEUTIC USE OF THE BOTULINUM NEUROTOXIN SEROTYPE A
[patent_app_type] => utility
[patent_app_number] => 16/252972
[patent_app_country] => US
[patent_app_date] => 2019-01-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5149
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16252972
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/252972 | Therapeutic use of the botulinum neurotoxin serotype A | Jan 20, 2019 | Issued |
Array
(
[id] => 16695517
[patent_doc_number] => 10946086
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-16
[patent_title] => Group B
[patent_app_type] => utility
[patent_app_number] => 16/245378
[patent_app_country] => US
[patent_app_date] => 2019-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 25
[patent_figures_cnt] => 25
[patent_no_of_words] => 47493
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 63
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16245378
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/245378 | Group B | Jan 10, 2019 | Issued |